Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

NCT00027339 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: lopinavir/ritonavir
DRUG: indinavir sulfate
DRUG: tenofovir disoproxil fumarate
DRUG: ritonavir
DRUG: fosamprenavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)